Citation Impact
Citing Papers
Corneal Wound Healing Effects of Mesenchymal Stem Cell Secretome Delivered Within a Viscoelastic Gel Carrier
2019
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Effect of Hypotonic 0.18% Sodium Hyaluronate Eyedrops on Inflammation of the Ocular Surface in Experimental Dry Eye
2014
Cell and Molecular Biology of Human Lacrimal Gland and Nasolacrimal Duct Mucins
2006
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
A cross-linked hyaluronan gel accelerates healing of corneal epithelial abrasion and alkali burn injuries in rabbits
2010
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
2009 Standout
Syphilis
2016 Standout
Small-Vessel Vasculitis
1997 Standout
Hidradenitis suppurativa: A comprehensive review
2009 Standout
MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis
1997
Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro
2004
Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment
2008
Infectious Uveitis in Immunocompromised Patients and the Diagnostic Value of Polymerase Chain Reaction and Goldmann-Witmer Coefficient in Aqueous Analysis
2007
Sodium Hyaluronate Decreases Ocular Surface Toxicity Induced by Benzalkonium Chloride–Preserved Latanoprost: An In Vivo Study
2013
Adult Retinal Pigment Epithelial Transplantation in Exudative Age-related Macular Degeneration
2007
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Evidence‐based treatment of systemic vasculitis
2000
Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy
2008
Generation of retinal cells from mouse and human induced pluripotent stem cells
2009 StandoutNobel
Autoimmune stiff person syndrome and related myelopathies: Understanding of electrophysiological and immunological processes
2011
TFOS DEWS II pathophysiology report
2017 Standout
Biomedical applications of biodegradable polymers
2011 Standout
Subconjunctival Bevacizumab Immediately After Excision of Primary Pterygium: The First Clinical Trial
2011
Influence of Interleukin 10 and Transforming Growth Factor-β on T Cell Stimulation through Allogeneic Retinal Pigment Epithelium Cells in vitro
2002
Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1
2006
Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis
1998
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2000 Standout
Efficacy of Intralesional Bevacizumab Injection in Decreasing Pterygium Size
2010
Effect of Hypotonic 0.4% Hyaluronic Acid Drops in Dry Eye Patients: A Cross-Over Study
2008
TFOS DEWS II Management and Therapy Report
2017 Standout
Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer
2003
Therapy for the maintenance of remission in sixty‐five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole
1996
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
2002 Standout
Primary systemic vasculitis
1997
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
2007
Effect of Subconjunctival Bevacizumab on Primary Pterygium
2009
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Pathogenesis of ANCA-associated systemic vasculitis
2000
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
2009
A Review of the Use of Infliximab to Manage Cutaneous Dermatoses
2004
Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia.
2017 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Trefoil Factor Family Peptide 3 (TFF3) is Upregulated Under Experimental Conditions Similar to Dry Eye Disease and Supports Corneal Wound Healing Effects In Vitro
2014
Efficacy of Topical Bevacizumab for Inhibiting Growth of Impending Recurrent Pterygium
2009
The Spectrum of Vasculitis
1978 Standout
UK National Guidelines on the Management of Syphilis 2008
2008
WEGENER'S GRANULOMATOSIS
1995
Detection of Surfactant Proteins A and D in Human Tear Fluid and the Human Lacrimal System
2007
UK national guidelines on the management of syphilis 2015
2015 Standout
Trefoil Factor Family Peptide 3 at the Ocular Surface. A Promising Therapeutic Candidate for Patients with Dry Eye Syndrome?
2010
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
A Review of the Use of Infliximab to Manage Cutaneous Dermatoses
2004
Wegener's Granulomatosis
1974
Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years
1983 Standout
Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
2017 StandoutNobel
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of B. Nölle being referenced
Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease
1996
Expression of adhesion molecule CD44 on human corneas
1997
Detection of Treponema pallidum in the vitreous by PCR
2006
Distribution of TFF peptides in corneal disease and pterygium
2004
Remissionsinduktion mit Infliximab bei therapierefraktärer Wegenerscher Granulomatose - Verlaufsbeobachtung
2002
Immune-mediated retinopathy in a patient with stiff-man syndrome
1999
Orbital Involvement in Wegener’s Granulomatosis
1993
ANCA in Ocular Inflammatory Disorders
1993
Orbitale Beteiligung bei Wegenerscher Granulomatose
1992
Expression of MHC class I and II molecules by cadaver retinal pigment epithelium cells: optimization of post-mortem HLA typing
1991
Differential Expression of Vascular Endothelial Growth Factor Implies the Limbal Origin of Pterygia
2005
[Paraneoplastic retinopathy in 2 patients with breast carcinoma].
1997